KLP Kapitalforvaltning’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.3M Sell
615,456
-21,300
-3% -$1.16M 0.08% 224
2026
Q1
$40M Buy
636,756
+26,200
+4% +$2.1M 0.16% 118
2025
Q4
$58.2M Sell
610,556
-2,100
-0.3% -$206K 0.22% 82
2025
Q3
$59.8M Sell
612,656
-1,400
-0.2% -$145K 0.24% 77
2025
Q2
$66M Buy
614,056
+26,300
+4% +$2.66M 0.28% 64
2025
Q1
$59.3M Sell
587,756
-7,900
-1% -$795K 0.29% 62
2024
Q4
$53.2M Buy
+595,656
New +$52.4M 0.25% 69

Other funds holding BSX

KLP Kapitalforvaltning's BSX Position: Q2 2026 in Review

KLP Kapitalforvaltning reduced its Boston Scientific (BSX) stake by 3.3% in Q2 2026, selling an estimated $1.16M and leaving 615,456 shares worth $26.3M. The position accounts for 0.08% of the portfolio, ranked #224.

KLP Kapitalforvaltning first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $66M in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • KLP Kapitalforvaltning held 615,456 shares of Boston Scientific worth $26.3M as of Q2 2026.
  • KLP Kapitalforvaltning sold 21,300 Boston Scientific shares in Q2 2026, an estimated $1.16M.
  • Boston Scientific made up 0.08% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #224 holding.
  • KLP Kapitalforvaltning first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
  • KLP Kapitalforvaltning's Boston Scientific position peaked at $66M in Q2 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.